Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.

Dr Alistair Vickery

Medical Director: Emerald Clinics
Recent posts
cannabis and driving ajgp tom arkell cover

Scientific Research: Cannabis Vs Other Drugs & Driving

Recently I co-authored an article called Cannabis & Driving, which was published in the Australian Journal of General Practice. The report reviewed the scientific evidence regarding cannabis and driving impairment. It also discusses the legal issues affecting patients and physicians. The findings lead us to conclude that medicinal cannabis should be treated the same way […]

Read more
drive change public submission national transport commission blog cover

Drive Change Submission to NTC: Assessing Fitness to Drive

On the 11th of June 2021, the Drive Change Team responded to the National Transport Commission’s Assessment of Fitness To Drive Interim Report public consultation. We were lucky to have a majority of our Ambassadors, Supporters and Friends sign on to the submission, which we believe shows great support for ending discrimination toward medicinal cannabis […]

Read more